Literature DB >> 29086911

Maternal cardiac output response to colloid preload and vasopressor therapy during spinal anaesthesia for caesarean section in patients with severe pre-eclampsia: a randomised, controlled trial.

R A Dyer1, A Daniels1, A Vorster1, A Emmanuel1, M J Arcache1, S Schulein1, A R Reed1, C J Lombard2, M F James1, D van Dyk1.   

Abstract

We examined the haemodynamic effects of colloid preload, and phenylephrine and ephedrine administered for spinal hypotension, during caesarean section in 42 women with severe early onset pre-eclampsia. Twenty patients with pre-delivery spinal hypotension were randomly allocated to receive an initial dose of either 50 μg phenylephrine or 7.5 mg ephedrine; the primary outcome was percentage change in cardiac index. After a 300-ml colloid preload, mean (SD) cardiac index increased from 4.9 (1.1) to 5.6 (1.2) l.min-1 .m-2 (p < 0.01), resulting from an increase in both heart rate, from 81.3 (17.2) to 86.3 (16.5) beats.min-1 (p = 0.2), and stroke volume, from 111.8 (19.0) to 119.8 (17.9) ml (p = 0.049). Fourteen (33%) and 23 (54.8%) patients exhibited a stroke volume response > 10% and > 5%, respectively; a significant negative correlation was found between heart rate and stroke volume changes. Spinal hypotension in 20 patients was associated with an increase from baseline in cardiac index of 0.6 l.min-1 .m-2 (mean difference 11.5%; p < 0.0001). After a median [range] dose of 50 [50-150] μg phenylephrine or 15 [7.5-37.5] mg ephedrine, the percentage change in cardiac index during the measurement period of 150 s was greater, and negative, in patients receiving phenylephrine vs. ephedrine, at -12.0 (7.3)% vs. 2.6 (6.0)%, respectively (p = 0.0001). The percentage change in heart rate after vasopressor was higher in patients receiving phenylephrine, at -9.1 (3.4)% vs. 5.3 (12.6)% (p = 0.0027), as was the change in systemic vascular resistance, at 22.3 (7.5) vs. -1.9 (10.5)% (p < 0.0001). Phenylephrine effectively reverses spinal anaesthesia-induced haemodynamic changes in severe pre-eclampsia, if left ventricular systolic function is preserved.
© 2017 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Keywords:  blood pressure; cardiac output measurement; ephedrine; hypotension; phenylephrine; pre-eclampsia; preload; spinal anaesthesia; vasopressors

Mesh:

Substances:

Year:  2017        PMID: 29086911     DOI: 10.1111/anae.14040

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

Review 1.  [Hypotension induced by spinal anesthesia during cesarean section : Current treatment concepts].

Authors:  R Fantin; C M Ortner; K U Klein; G Putz; D Marhofer; S Jochberger
Journal:  Anaesthesist       Date:  2020-04       Impact factor: 1.041

2.  Association between intraoperative phenylephrine administration and umbilical artery pH in women with hypertensive disorders of pregnancy: a retrospective cohort study.

Authors:  Takahiko Kaneko; Nobutaka Kariya; Munetaka Hirose
Journal:  J Anesth       Date:  2018-10-30       Impact factor: 2.078

Review 3.  Vasopressors for the Treatment and Prophylaxis of Spinal Induced Hypotension during Caesarean Section.

Authors:  Ebru Biricik; Hakkı Ünlügenç
Journal:  Turk J Anaesthesiol Reanim       Date:  2020-05-05

4.  Clinical Effects of Integrated Traditional Chinese and Western Medicine in Treating Severe Preeclampsia and Its Influence on Maternal and Infant Outcomes after Cesarean Section under Combined Lumbar and Epidural Anesthesia.

Authors:  Xiaolu Wang; Wenpeng Wei; Yanyan Qi; Lihua Dong; Yun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-08       Impact factor: 2.629

5.  Comparative Dose-Response Study of Phenylephrine Bolus for the Treatment of the First Episode of Spinal Anesthesia-Induced Hypotension for Cesarean Delivery in Severe Preeclamptic versus Normotensive Parturients.

Authors:  Li-Juan Hu; Zhong Mei; Yan-Ping Shen; Hao-Tian Sun; Zhi-Min Sheng; Xin-Zhong Chen; Xiao-Wei Qian
Journal:  Drug Des Devel Ther       Date:  2022-07-08       Impact factor: 4.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.